Finance

Lists
VTGN:BMV
Vistagen Therapeutics Inc
MX$10.65
+161.67%
(+6.58) 1D
Apr 21, 1:54:16 PM GMT-6  ·   MXN
All symbols
SymbolPriceChange% Change
Generating top insights for VTGN...
Mkt. cap
9.13M
Avg. vol.
0.00
Volume
0.00
52-wk high
MX$12.26
52-wk low
MX$3.90
No. of employees
41
Mkt. cap
9.13M
Avg. vol.
0.00
Volume
0.00
52-wk high
MX$12.26
52-wk low
MX$3.90
No. of employees
41
News stories
From sources across the web
About Vistagen Therapeutics Inc
CEO-
Employees41
Founded1998
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitevistagen.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
244.00K
258.00K
303.00K
465.00K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
11.68M
15.92M
14.22M
13.06M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.37M
4.40M
5.63M
4.12M
Operating expense
16.05M
20.31M
19.85M
17.18M
Total operating expenses
16.05M
20.31M
19.85M
17.18M
Operating income
-15.80M
-20.05M
-19.55M
-16.72M
Other non operating income
-2.00K
6.00K
-
-2.00K
EBT including unusual items
-15.10M
-19.42M
-18.90M
-16.27M
EBT excluding unusual items
-15.10M
-19.42M
-18.90M
-16.27M
Income tax expense
-
-
-
7.00K
Effective tax rate
-
-
-
-0.04%
Other operating expenses
-
-
-
-
Net income
-15.10M
-19.42M
-18.90M
-16.27M
Net profit margin
-6,186.48%
-7,525.97%
-6,237.29%
-3,499.78%
Earnings per share
-0.47
-0.54
-0.45
-0.37
Interest and investment income
711.00K
630.00K
647.00K
452.00K
Interest expense
-
-
-
-
Net interest expenses
711.00K
630.00K
647.00K
452.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-15.76M
-20.00M
-19.49M
-16.66M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer